BE894286A - PHARMACEUTICAL COMPOSITION CONTAINING NON-STEROID SYSTEMIC ANTI-INFLAMMATORY DRUG AND 1-METHYL-5 - ((3- (3- (3- (1-PIPERIDINYLMETHYL) PHENOXY) -PROPYL) AMINO -1H-1,2,4-TRIAZOLE-3- METHANOL OR A SALT OF THIS COMPOUND - Google Patents
PHARMACEUTICAL COMPOSITION CONTAINING NON-STEROID SYSTEMIC ANTI-INFLAMMATORY DRUG AND 1-METHYL-5 - ((3- (3- (3- (1-PIPERIDINYLMETHYL) PHENOXY) -PROPYL) AMINO -1H-1,2,4-TRIAZOLE-3- METHANOL OR A SALT OF THIS COMPOUNDInfo
- Publication number
- BE894286A BE894286A BE0/208937A BE208937A BE894286A BE 894286 A BE894286 A BE 894286A BE 0/208937 A BE0/208937 A BE 0/208937A BE 208937 A BE208937 A BE 208937A BE 894286 A BE894286 A BE 894286A
- Authority
- BE
- Belgium
- Prior art keywords
- piperidinylmethyl
- triazole
- phenoxy
- propyl
- methanol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8126787 | 1981-09-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
BE894286A true BE894286A (en) | 1983-03-02 |
Family
ID=10524317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/208937A BE894286A (en) | 1981-09-04 | 1982-09-02 | PHARMACEUTICAL COMPOSITION CONTAINING NON-STEROID SYSTEMIC ANTI-INFLAMMATORY DRUG AND 1-METHYL-5 - ((3- (3- (3- (1-PIPERIDINYLMETHYL) PHENOXY) -PROPYL) AMINO -1H-1,2,4-TRIAZOLE-3- METHANOL OR A SALT OF THIS COMPOUND |
Country Status (18)
Country | Link |
---|---|
JP (1) | JPS5855421A (en) |
KR (1) | KR840001276A (en) |
AU (1) | AU8799882A (en) |
BE (1) | BE894286A (en) |
DE (1) | DE3232831A1 (en) |
DK (1) | DK396582A (en) |
FI (1) | FI823041L (en) |
FR (1) | FR2512343A1 (en) |
GB (1) | GB2105588B (en) |
GR (1) | GR76433B (en) |
IL (1) | IL66709A0 (en) |
IT (1) | IT8249072A0 (en) |
LU (1) | LU84364A1 (en) |
NL (1) | NL8203456A (en) |
PT (1) | PT75504A (en) |
SE (1) | SE8205035L (en) |
ZA (1) | ZA826479B (en) |
ZW (1) | ZW18582A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4636498A (en) * | 1984-10-11 | 1987-01-13 | Pfizer Inc. | Formulation of antiinflammatory drugs |
US4567179A (en) * | 1984-10-11 | 1986-01-28 | Pfizer, Inc. | Antiinflammatory salts of piroxicam |
GB8805268D0 (en) * | 1988-03-04 | 1988-04-07 | Glaxo Group Ltd | Medicaments |
EP2374478B1 (en) * | 2008-12-04 | 2017-08-23 | Next 21 K.K. | Nsaid-disaccharide inclusion complexes for alleviating damage to the gastrointestinal mucosa |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU56680A (en) * | 1979-03-02 | 1983-04-30 | Glaxo Group Ltd | Process for obtaining new 1,2,4-triazole derivatives |
US4410523A (en) * | 1979-10-22 | 1983-10-18 | Glaxo Group Limited | Heterocyclic derivatives |
-
1982
- 1982-09-02 BE BE0/208937A patent/BE894286A/en not_active IP Right Cessation
- 1982-09-03 DE DE19823232831 patent/DE3232831A1/en not_active Withdrawn
- 1982-09-03 GB GB08225178A patent/GB2105588B/en not_active Expired
- 1982-09-03 NL NL8203456A patent/NL8203456A/en not_active Application Discontinuation
- 1982-09-03 DK DK396582A patent/DK396582A/en not_active Application Discontinuation
- 1982-09-03 JP JP57153790A patent/JPS5855421A/en active Pending
- 1982-09-03 ZW ZW185/82A patent/ZW18582A1/en unknown
- 1982-09-03 AU AU87998/82A patent/AU8799882A/en not_active Abandoned
- 1982-09-03 SE SE8205035A patent/SE8205035L/en not_active Application Discontinuation
- 1982-09-03 GR GR69199A patent/GR76433B/el unknown
- 1982-09-03 LU LU84364A patent/LU84364A1/en unknown
- 1982-09-03 FR FR8215043A patent/FR2512343A1/en not_active Withdrawn
- 1982-09-03 IT IT8249072A patent/IT8249072A0/en unknown
- 1982-09-03 KR KR1019820003975A patent/KR840001276A/en unknown
- 1982-09-03 FI FI823041A patent/FI823041L/en not_active Application Discontinuation
- 1982-09-03 PT PT75504A patent/PT75504A/en unknown
- 1982-09-03 ZA ZA826479A patent/ZA826479B/en unknown
- 1982-09-03 IL IL66709A patent/IL66709A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
SE8205035L (en) | 1983-03-05 |
IL66709A0 (en) | 1982-12-31 |
FI823041A0 (en) | 1982-09-03 |
GB2105588A (en) | 1983-03-30 |
GR76433B (en) | 1984-08-10 |
ZA826479B (en) | 1984-04-25 |
IT8249072A0 (en) | 1982-09-03 |
DE3232831A1 (en) | 1983-03-24 |
NL8203456A (en) | 1983-04-05 |
KR840001276A (en) | 1984-04-30 |
SE8205035D0 (en) | 1982-09-03 |
AU8799882A (en) | 1983-03-10 |
FR2512343A1 (en) | 1983-03-11 |
LU84364A1 (en) | 1984-04-24 |
FI823041L (en) | 1983-03-05 |
GB2105588B (en) | 1984-07-18 |
DK396582A (en) | 1983-03-05 |
JPS5855421A (en) | 1983-04-01 |
PT75504A (en) | 1982-10-01 |
ZW18582A1 (en) | 1984-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2508318B1 (en) | BANDAGE FOR THE ADMINISTRATION OF A PHARMACEUTICAL SUBSTANCE | |
FR2586562B1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING A-METHYLHISTAMINE | |
DZ315A1 (en) | Powder based on bacampicillin acid addition salt micro-encaspsule and pharmaceutical composition containing it. | |
PT67365A (en) | PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING NEW ORGANIC COMPOUNDS | |
FR2582513B1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING ALFUZOSINE | |
BE885441A (en) | DERIVATIVES OF NON-STEROID ANTI-INFLAMMATORY AGENTS, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
BE893193A (en) | PHARMACEUTICAL COMPOSITION CONTAINING 24-25-DIHYDROXY-CHOLECALCIFEROL AS ACTIVE INGREDIENT | |
BE828666A (en) | PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION CONTAINING ZINC SUITABLE FOR MEDICAL USE | |
FR2527597B1 (en) | ALCOHOL B DERIVATIVES, G-DIHYDROPOLYPRENYLIC AND PHARMACEUTICAL COMPOSITION CONTAINING A POLYPRENYLIC COMPOUND | |
FR2480603B1 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION CONTAINING CYTIDINE-DIPHOSPHOCHOLINE | |
BE879472A (en) | PHARMACEUTICAL COMPOSITION CONTAINING 3,4-DIHYDRO-3-OXO-2-QUINOXALINES | |
BE894286A (en) | PHARMACEUTICAL COMPOSITION CONTAINING NON-STEROID SYSTEMIC ANTI-INFLAMMATORY DRUG AND 1-METHYL-5 - ((3- (3- (3- (1-PIPERIDINYLMETHYL) PHENOXY) -PROPYL) AMINO -1H-1,2,4-TRIAZOLE-3- METHANOL OR A SALT OF THIS COMPOUND | |
PT68306A (en) | PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING NEW ORGANIC COMPOUNDS | |
PT66120A (en) | PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING NEW ORGANIC COMPOUNDS | |
FR2556218B1 (en) | PHARMACEUTICAL PRODUCT FOR LOCAL APPLICATION CONSTITUTED BY THE ASSOCIATION OF AN ACTIVE MEDICINAL PRINCIPLE-ENZYMATIC AGENT | |
FR2550091B1 (en) | PHARMACEUTICAL OR VETERINARY COMPOSITION FOR COMBATING CARDIAC ISCHEMIC DISORDERS CONTAINING A BENZOFURAN DERIVATIVE | |
PT65264A (en) | PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING ORGANIC COMPOUNDS | |
FR2512342B1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING AN ANTI-INFLAMMATORY MEDICINAL PRODUCT AND RANITIDINE OR A SALT THEREOF | |
FR2585953B1 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION CONTAINING UBIQUINONE AND METHOD | |
PT67562B (en) | PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING NEW ORGANIC COMPOUNDS | |
PT68062A (en) | PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING NEW ORGANIC COMPOUNDS | |
FR2509611B1 (en) | NOVEL ACID AGENT AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | |
PT64839A (en) | PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING NEW ORGANIC COMPOUNDS | |
PT68345A (en) | PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING NEW ORGANIC COMPOUNDS | |
PT67791A (en) | PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION CONTAINING ORGANIC COMPOUNDS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: GLAXO GROUP LTD Effective date: 19840902 |